BRENNAN AOIFE (President and CEO) sold 30.0% of their position (20.62K shares) of CLIMB BIO, INC. on the open market
Open‑market sale worth $25.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2025ACC: 0000950170-25-092284
DirectorOfficer· President and CEO
Since Jun 2024
-20.62K
Net shares
Net seller
$25.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
68.75K acquired · 89.37K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+68.75K
Price / share
—
Trade value
—
% of position
New position
6/27/2025
0.00→68.75K
Common Stock
Direct
Shares
−20.62K
Price / share
$1.22
Trade value
$25.15K
% of position
30.0%
6/30/2025
68.75K→48.13K
Total
Net shares
+48.13K
Net value
-$25.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/27/2025 | M · Option Exercise | +68.75K | — | — | New position | 0.00 | 68.75K |
| Common Stock Direct | 6/30/2025 | S · Sale | −20.62K | $1.22 | $25.15K | 30.0% | 68.75K | 48.13K |
| Total | +48.13K | -$25.15K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
68.75K shares
Shares
−68.75K
Strike price
Held after
206.25K
Exercisable
—
6/27/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock68.75K shares | 6/27/2025 | M · Option Exercise | −68.75K | — | 206.25K |